Moderna (NasdaqGS:MRNA) saw an 11% increase in share price over the last week, likely influenced by recent legal and financial developments. The announcement of multiple international lawsuits from ...
U.S. President Donald Trump has nominated John Squires, the former chief intellectual property attorney at banking giant ...
President Donald Trump’s pick to lead the US Patent and Trademark Office is setting off alarm bells for tech companies and ...
Agilent Technologies Inc. and Synthego Corp. sparred Friday over whether Agilent patents related to a key component of the ...
Traeger’s IoT and app tech investments fuel growth in a booming market. Read why COOK stock is a buy, with strong revenue ...
Viatris Inc. (VTRS) recently reported a fourth quarter that fell short of Wall Street expectations, missing revenue and ...
Ford is always filing some new bizarre patent application. This latest one would have you talking shop with Ford Engineers in ...
Investing $25,000 in each of these six ultra-high-yield stocks will pay out over $21,000 per year in passive income.
This week in Other Barks & Bites: the UK Court of Appeal grants Lenovo an interim cross-license after finding that Ericsson ...
Hosted on MSN14d
Collegium Pharmaceutical’s (NASDAQ:COLL) Q4 Sales Top Estimates, Stock Jumps 14.1%Pharmaceutical company Collegium Pharmaceutical (NASDAQ:COLL) reported Q4 CY2024 results , with sales up 21.5% year on year to $181.9 million. The company expects the full year’s revenue to be around ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results